Iovance Biotherapeutics, Inc. IOVA
6.90 USD -0.41 (-5.61%)
Regular-session close
6.98 +0.08 +1.16%
After hours · Nov 20, 7:32 PM ET
6.77 Day range 7.40
2.08 52-week range 15.37
- YTD
- +152.75%
- 1 year
- +216.51%
Revenue & Expenses
Revenue by
Revenue Profit Costs
Latest period ending Dec 31, 2025 · select a line to chart its full history
Income statement
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 263.50M | 164.07M | 1.19M | 0 | 0 | |
| 90.32M | 70.82M | 156.00K | 0 | 0 | |
| -403.36M | -395.28M | -460.56M | -398.88M | -342.70M | |
| -390.98M | -372.18M | -444.04M | -395.89M | -342.25M | |
| -1.09 | -1.28 | -1.89 | -2.49 | -2.23 |
Balance sheet
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 169.06M | 122.05M | 181.32M | 238.16M | 84.31M | |
| 913.17M | 910.43M | 780.35M | 663.98M | 777.33M | |
| 214.59M | 200.02M | 195.74M | 164.34M | 155.67M | |
| 49.44M | 58.26M | 75.86M | 85.45M | 71.53M | |
| 698.58M | 710.40M | 584.61M | 499.64M | 621.66M |
Cash flow
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| -302.41M | -352.98M | -361.82M | -292.76M | -227.94M | |
| 47.50M | -96.41M | -155.24M | 256.45M | 132.00K | |
| 300.77M | 390.66M | 462.96M | 190.15M | 239.27M | |
| -33.84M | -11.07M | -22.29M | -20.43M | -37.57M | |
| 47.01M | -59.27M | -56.84M | 153.85M | 11.46M |
